Literature DB >> 6376377

Abnormal properties of skin fibroblasts from patients with breast cancer.

B Azzarone, M Mareel, C Billard, P Scemama, C Chaponnier, A Macieira-Coelho.   

Abstract

The growth properties of fibroblasts from the thoracic skin of patients with mammary cancers were compared to those of fibroblastic cultures from patients with benign lesions or having undergone surgery for non-neoplastic diseases. As expected, an inverse correlation was found between the doubling potential of fibroblasts in vitro and the donor's age for cells from patients with benign lesions; however no correlation, was found with cultures from cancer patients. Moreover, the latter group responded in an abnormal way to three biological parameters: anchorage dependence, colony formation on monolayers of normal human epithelial cells and saturation densities in overcrowded culture conditions. Skin fibroblasts from one patient with a benign lesion, whose mother had developed a breast cancer, displayed all the abnormal growth properties. Periodic controls of this patient resulted in the early detection of a carcinoma 3 years after the first operation for a benign microcystic lesion. Finally, we found that multiple subcultivations in overcrowded culture conditions cause the selection of a fibroblastic cell subset with greater growth potential which, in the cell strain tested, could invade foreign tissue in vitro.

Entities:  

Mesh:

Year:  1984        PMID: 6376377     DOI: 10.1002/ijc.2910330608

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: an in situ hybridization and immunohistochemistry study.

Authors:  C Giani; K J Cullen; D Campani; A Rasmussen
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 2.  Mammary stroma in development and carcinogenesis.

Authors:  Teruyo Sakakura; Yuka Suzuki; Robert Shiurba
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-04-21       Impact factor: 2.673

3.  Stromal IGF-II messenger RNA in breast cancer: relationship with progesterone receptor expressed by malignant epithelial cells.

Authors:  C Giani; A Pinchera; A Rasmussen; P Fierabracci; R Bonacci; D Campini; G Bevilacqua; B Trock; M E Lippman; K J Cullen
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

4.  Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.

Authors:  Carolina S Ilkow; Monique Marguerie; Cory Batenchuk; Justin Mayer; Daniela Ben Neriah; Sophie Cousineau; Theresa Falls; Victoria A Jennings; Meaghan Boileau; David Bellamy; Donald Bastin; Christiano Tanese de Souza; Almohanad Alkayyal; Jiqing Zhang; Fabrice Le Boeuf; Rozanne Arulanandam; Lawton Stubbert; Padma Sampath; Steve H Thorne; Piriya Paramanthan; Avijit Chatterjee; Robert M Strieter; Marie Burdick; Christina L Addison; David F Stojdl; Harold L Atkins; Rebecca C Auer; Jean-Simon Diallo; Brian D Lichty; John C Bell
Journal:  Nat Med       Date:  2015-04-20       Impact factor: 53.440

5.  Mammary fibroblasts stimulate growth, alveolar morphogenesis, and functional differentiation of normal rat mammary epithelial cells.

Authors:  K M Darcy; D Zangani; W Shea-Eaton; S F Shoemaker; P P Lee; L H Mead; A Mudipalli; R Megan; M M Ip
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-10       Impact factor: 2.416

6.  Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype.

Authors:  Harry Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

7.  Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic and synthesis.

Authors:  S L Schor; A M Schor; A M Grey; J Chen; G Rushton; M E Grant; I Ellis
Journal:  In Vitro Cell Dev Biol       Date:  1989-08

8.  Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.

Authors:  A M Grey; A M Schor; G Rushton; I Ellis; S L Schor
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition.

Authors:  Isaac P Horn; David L Marks; Amanda N Koenig; Tara L Hogenson; Luciana L Almada; Lauren E Goldstein; Paola A Romecin Duran; Renzo Vera; Anne M Vrabel; Gaofeng Cui; Kari G Rabe; William R Bamlet; Georges Mer; Hugues Sicotte; Cheng Zhang; Hu Li; Gloria M Petersen; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2021-04-03       Impact factor: 5.157

Review 10.  Immune interactions in hepatic fibrosis.

Authors:  Andrew P Holt; Mike Salmon; Christopher D Buckley; David H Adams
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.